Open Access. Powered by Scholars. Published by Universities.®
- Discipline
-
- Intellectual Property Law (7)
- Science and Technology Law (2)
- Agriculture Law (1)
- Amino Acids, Peptides, and Proteins (1)
- Biological Engineering (1)
-
- Biomedical Devices and Instrumentation (1)
- Biomedical Engineering and Bioengineering (1)
- Chemicals and Drugs (1)
- Engineering (1)
- Food and Drug Law (1)
- Health Law and Policy (1)
- Insurance Law (1)
- Legal Ethics and Professional Responsibility (1)
- Medicine and Health Sciences (1)
- Molecular, Cellular, and Tissue Engineering (1)
- Other Biomedical Engineering and Bioengineering (1)
- Pharmacology, Toxicology and Environmental Health (1)
- Pharmacy and Pharmaceutical Sciences (1)
- Keyword
-
- Biotechnology (7)
- Diamond v. Chakrabarty (3)
- Patent Act (2)
- Patent Law (2)
- Patent and Trademark Office (2)
-
- Patents (2)
- 1995 Amendment to 35 U.S.C. (1)
- 35 U.S.C. Sec. 271 (f) (1)
- 35 U.S.C. § 271 (f) (1)
- Agriculture (1)
- Ass'n for Molecular Pathology (1)
- Autonomy Paradigm (1)
- BRCA 1 (1)
- BRCA 2 (1)
- Bioethics (1)
- Brenner v. Manson (1)
- Contemporary Bioethical Landscape (1)
- DNA (1)
- Developing countries (1)
- Enablement Requirement (1)
- Enzo Biochem v. Calgene (1)
- Erlotinib (1)
- FDA (1)
- Federal Circuit (1)
- Gene patents (1)
- Genetic engineering (1)
- Human Gene Sequences (1)
- IVCDD (1)
- IVD (1)
- Intellectual property (1)
Articles 1 - 8 of 8
Full-Text Articles in Biotechnology
Intellectual Property, Surrogate Licensing, And Precision Medicine, Jacob S. Sherkow, Jorge L. Contreras
Intellectual Property, Surrogate Licensing, And Precision Medicine, Jacob S. Sherkow, Jorge L. Contreras
IP Theory
The fruits of the biotechnology revolution are beginning to be harvested. Recent regulatory approvals of a variety of advanced therapies—Keytruda (pembrolizumab), Kymriah (tisagenlecleucel), and patisiran—have ushered in an age of “precision medicine” treatments that target patients’ specific genetic, physiological, and environmental profiles rather than generalized diagnoses of disease. Therapies like these may soon be supplemented by gene editing technologies such as CRISPR, which could enable the targeted eradication of deleterious genetic variants to improve human health. But the intellectual property (IP) surrounding precision therapies and their foundational technology remain controversial. Precision therapies ultimately rely—and are roughly congruent with—basic scientific information …
A Thousand Tiny Pieces: The Federal Circuit’S Fractured Myriad Ruling, Lessons To Be Learned, And The Way Forward, Jonathan R. K. Stroud
A Thousand Tiny Pieces: The Federal Circuit’S Fractured Myriad Ruling, Lessons To Be Learned, And The Way Forward, Jonathan R. K. Stroud
IP Theory
No abstract provided.
Combining The Components Of Life: The Application Of Patent Extraterritoriality Doctrine To Biotechnology, Jennifer L. Schuster
Combining The Components Of Life: The Application Of Patent Extraterritoriality Doctrine To Biotechnology, Jennifer L. Schuster
Indiana Law Journal
No abstract provided.
Patenting Resources: Biotechnology And The Concept Of Sustainable Development, Yvonne Cripps
Patenting Resources: Biotechnology And The Concept Of Sustainable Development, Yvonne Cripps
Indiana Journal of Global Legal Studies
No abstract provided.
Making Sense Out Of Antisense: The Enablement Requirement In Biotechnology After Enzo Biochem V. Calgene, Matthew D. Kellam
Making Sense Out Of Antisense: The Enablement Requirement In Biotechnology After Enzo Biochem V. Calgene, Matthew D. Kellam
Indiana Law Journal
No abstract provided.
Pregnant With Ambiguity: Credibility And The Pto Utility Guidelines In Light Of Brenner, Andrew T. Kight
Pregnant With Ambiguity: Credibility And The Pto Utility Guidelines In Light Of Brenner, Andrew T. Kight
Indiana Law Journal
No abstract provided.
Beyond The Harvard Mouse: Current Patent Practice And The Necessity Of Clear Guidelines In Biotechnology Patent Law, Carrie F. Walter
Beyond The Harvard Mouse: Current Patent Practice And The Necessity Of Clear Guidelines In Biotechnology Patent Law, Carrie F. Walter
Indiana Law Journal
No abstract provided.
Paradigms And Our Shrinking Bioethics, Peter Cherbas
Paradigms And Our Shrinking Bioethics, Peter Cherbas
Indiana Law Journal
Symposium: Emerging Paradigms in Bioethihcs